Immunocore Holdings plc

NasdaqGS:IMCR Stock Report

Mkt Cap: US$2.9b

Immunocore Holdings Financial Health

How is Immunocore Holdings's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: IMCR's short term assets (£403.5M) exceed its short term liabilities (£77.2M).

Long Term Liabilities: IMCR's short term assets (£403.5M) exceed its long term liabilities (£72.6M).

Debt to Equity History and Analysis

Debt Level: IMCR has more cash than its total debt.

Reducing Debt: IMCR's debt to equity ratio has increased from 8.7% to 15.5% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IMCR has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if IMCR has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Discover healthy companies